Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Rubberbandon Sep 05, 2021 11:20am
138 Views
Post# 33815455

RE:RE:RE:RE:Read 2nd Paragraph

RE:RE:RE:RE:Read 2nd ParagraphSylvain has a very long pedigree. A very well repected person in the health care field. Just look back at his time at Aspen Pharma. As when it comes to another P.P. if they need the cash to continue where we want this company to be then they do it. If they do a RS then they do it. We will be fine in the coming months. I again IMO believe there will be significant news release coming shortly as the 2nd quarter was just released. But I will say this, it is very nice seeing David Hennigar putting some skin on the table. If right there does not give some type of balance in what many on this board like to bash about then there is not much more to say. Keep smiling it will happen. Rubberband.
<< Previous
Bullboard Posts
Next >>